Artwork
iconShare
 
Manage episode 520947742 series 3579126
Content provided by Gene Quinn. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Gene Quinn or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

Send us a text

This week on IPWatchdog Unleashed, we panel discussion that took place on October 27 as a part of our annual life sciences program. Initially styled as a conversation about how artificial intelligence is transforming life sciences, it becomes quickly apparent that the conversation was not going to be limited to the life sciences sector but instead was a robust discussion about what any innovative company should consider when considering the adoption of AI tools. Indeed, the discuss was really about what all companies must do to allow or even encourage the use of AI by researchers and scientists without opening catastrophic IP and data-security failures, risk and liability. We address data protection, trade secret risks, employee monitoring, AI governance, the importance of using AI responsibly, and much more.
Moderated by Gene Quinn, founder of IPWatchdog, the conversation brought together Brian Cocca, Executive Director & Assistant General Counsel for IP at Regeneron; Gary Lobel, Chief IP Counsel; Drhuv Sud, Senior Director & Assistant General Counsel at Regeneron; and Giulia Toti, co-founder of Anchor AI. Collectively, the panel unpacked the real-world collision between AI adoption, IP protection, data governance, competitive strategy and risk.

Visit us online at IPWatchdog.com.
You can also visit our channels at YouTube, LinkedIn, X, Instagram and Facebook.

  continue reading

77 episodes